This is consistent with MeRIP-seq analysis reported by Li and colleagues that showed m6A modification peaks were enriched in the Metabolic, TNF signalling, and PI3K-Akt–related transcripts in glioma stem cells48. The gene discussed is AKT1; the disease is central nervous system cancer.